Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson’s Disease: Longitudinal Data from the Jönköping Parkinson Registry

Background. Orofacial symptoms are common in Parkinson’s disease (PD) both as initial manifestations and late markers of disease complications. We aimed to investigate the evolution of orofacial manifestations and their prognostic value throughout PD progression. Methods. Data was obtained from “Jön...

Full description

Saved in:
Bibliographic Details
Main Authors: Seyed-Mohammad Fereshtehnejad, Örjan Skogar, Johan Lökk
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2017/7802819
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566984753020928
author Seyed-Mohammad Fereshtehnejad
Örjan Skogar
Johan Lökk
author_facet Seyed-Mohammad Fereshtehnejad
Örjan Skogar
Johan Lökk
author_sort Seyed-Mohammad Fereshtehnejad
collection DOAJ
description Background. Orofacial symptoms are common in Parkinson’s disease (PD) both as initial manifestations and late markers of disease complications. We aimed to investigate the evolution of orofacial manifestations and their prognostic value throughout PD progression. Methods. Data was obtained from “Jönköping Parkinson Registry” database on routine care visits of 314 people with idiopathic PD in southern Sweden. Information on baseline symptomatology, orofacial features, UPDRS, and medications was recorded at baseline and during each follow-up visit within an average of 4.2 (range: 1–12) years. Results. Hypomimia, affected speech, drooling, and impaired swallowing were present in 37.3%/91.6%, 14.1%/65.5%, 11.7%/55.3%, and 10.2%/34.5% at baseline/follow-up, respectively. Male sex [OR = 2.4 (95% CI: 1.0–5.9)], UPDRS motor scores [OR = 1.2 (95% CI: 1.1–1.3)], dominant rigidity [OR = 5.2 (95% CI: 1.4–19.1)], and autonomic disturbance [OR = 3.4 (95% CI: 1.1–10.9)] were risk factors for drooling. Individuals with more severe orofacial burden at baseline had shorter median time to develop UPDRS-Part III > 28 [3rd tertile = 4.7 yr, 2nd tertile = 6.2 yr, and 1st tertile = 7.8 yr; p = 0.014]. Conclusions. Majority of people with PD manifest orofacial manifestations at either early or late stages of the disease. PD severity, symmetry of motor disturbances, and autonomic disorders correlate with orofacial symptoms. Individuals with more severe orofacial burden at baseline progressed faster to more advanced stages.
format Article
id doaj-art-b6649e1d8b184fad9586b5b5c2271e4c
institution Kabale University
issn 2090-8083
2042-0080
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-b6649e1d8b184fad9586b5b5c2271e4c2025-02-03T01:02:38ZengWileyParkinson's Disease2090-80832042-00802017-01-01201710.1155/2017/78028197802819Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson’s Disease: Longitudinal Data from the Jönköping Parkinson RegistrySeyed-Mohammad Fereshtehnejad0Örjan Skogar1Johan Lökk2Department of Neurology and Neurosurgery, McGill University, Montreal, QC, CanadaDivision of Clinical Geriatrics, Department of Neurobiology, Care Sciences, and Society (NVS), Karolinska Institutet, Stockholm, SwedenDivision of Clinical Geriatrics, Department of Neurobiology, Care Sciences, and Society (NVS), Karolinska Institutet, Stockholm, SwedenBackground. Orofacial symptoms are common in Parkinson’s disease (PD) both as initial manifestations and late markers of disease complications. We aimed to investigate the evolution of orofacial manifestations and their prognostic value throughout PD progression. Methods. Data was obtained from “Jönköping Parkinson Registry” database on routine care visits of 314 people with idiopathic PD in southern Sweden. Information on baseline symptomatology, orofacial features, UPDRS, and medications was recorded at baseline and during each follow-up visit within an average of 4.2 (range: 1–12) years. Results. Hypomimia, affected speech, drooling, and impaired swallowing were present in 37.3%/91.6%, 14.1%/65.5%, 11.7%/55.3%, and 10.2%/34.5% at baseline/follow-up, respectively. Male sex [OR = 2.4 (95% CI: 1.0–5.9)], UPDRS motor scores [OR = 1.2 (95% CI: 1.1–1.3)], dominant rigidity [OR = 5.2 (95% CI: 1.4–19.1)], and autonomic disturbance [OR = 3.4 (95% CI: 1.1–10.9)] were risk factors for drooling. Individuals with more severe orofacial burden at baseline had shorter median time to develop UPDRS-Part III > 28 [3rd tertile = 4.7 yr, 2nd tertile = 6.2 yr, and 1st tertile = 7.8 yr; p = 0.014]. Conclusions. Majority of people with PD manifest orofacial manifestations at either early or late stages of the disease. PD severity, symmetry of motor disturbances, and autonomic disorders correlate with orofacial symptoms. Individuals with more severe orofacial burden at baseline progressed faster to more advanced stages.http://dx.doi.org/10.1155/2017/7802819
spellingShingle Seyed-Mohammad Fereshtehnejad
Örjan Skogar
Johan Lökk
Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson’s Disease: Longitudinal Data from the Jönköping Parkinson Registry
Parkinson's Disease
title Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson’s Disease: Longitudinal Data from the Jönköping Parkinson Registry
title_full Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson’s Disease: Longitudinal Data from the Jönköping Parkinson Registry
title_fullStr Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson’s Disease: Longitudinal Data from the Jönköping Parkinson Registry
title_full_unstemmed Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson’s Disease: Longitudinal Data from the Jönköping Parkinson Registry
title_short Evolution of Orofacial Symptoms and Disease Progression in Idiopathic Parkinson’s Disease: Longitudinal Data from the Jönköping Parkinson Registry
title_sort evolution of orofacial symptoms and disease progression in idiopathic parkinson s disease longitudinal data from the jonkoping parkinson registry
url http://dx.doi.org/10.1155/2017/7802819
work_keys_str_mv AT seyedmohammadfereshtehnejad evolutionoforofacialsymptomsanddiseaseprogressioninidiopathicparkinsonsdiseaselongitudinaldatafromthejonkopingparkinsonregistry
AT orjanskogar evolutionoforofacialsymptomsanddiseaseprogressioninidiopathicparkinsonsdiseaselongitudinaldatafromthejonkopingparkinsonregistry
AT johanlokk evolutionoforofacialsymptomsanddiseaseprogressioninidiopathicparkinsonsdiseaselongitudinaldatafromthejonkopingparkinsonregistry